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Background: Depressive symptoms are associated with increased morbidity and mortality in individuals with coronary heart disease (CHD). The 
role of behavioral risk factors (BRFs) in this relationship is not clear.
Methods: Of the 30,239 REGARDS cohort participants, 4,676 had CHD at baseline and constituted the study sample. Scores ≥4 on the 4-item 
Center for Epidemiologic Studies Depression Scale indicated depressive symptoms. Incremental proportional hazards models were used to assess 
associations between depressive symptoms and definite/probable MI or death, adding disease-specific then BRFs to a model that included socio-
demographic covariates and body mass index.
Results: At baseline, 638 (13.6%) individuals in the study sample had depressive symptoms. Over a mean 3.5 years of follow up, 125 of 638 
(19.6%) participants with depressive symptoms and 657 of 4038 (16.3%) participants without had events. Depressive symptoms were associated 
with higher risk of events (hazard ratio [HR] 1.41 {95% CI 1.15-1.72}), but the increased risk was attenuated after BRFs were entered into the model 
(HR 1.17 {95% CI 0.96-1.43}) (see Table). Smoking (-17.6%) and physical inactivity (-21.1%) contributed the most to attenuating the associations.
Conclusion: Higher risk for MI or death among individuals with depressive symptoms was partly explained by BRFs, especially smoking and 
physical inactivity. Our findings have implications for behavioral interventions in individuals with CHD and depressive symptoms. 
Table Association between depressive symptoms (Center for Epidemiologic Studies Depression Scale of ≤4 vs >4) and clinical events (definite or probable MI or all-cause death). Models 
also included adjustment for geographic region of residence. * not included in regression model
Model 1 Model 2 Model 3
Depressive symptoms 1.41 (1.15 - 1.72) 1.29 (1.06 - 1.58) 1.17 (0.96 - 1.43)
Age, per 10 years 1.52 (1.39 - 1.65) 1.51 (1.39 - 1.65) 1.63 (1.49 - 1.79)
Male 1.44 (1.22 - 1.69) 1.43 (1.22 - 1.69) 1.52 (1.29 - 1.80)
Black 1.11 (0.94 - 1.30) 0.98 (0.83 - 1.15) 0.95 (0.81 - 1.12)
High school graduate 0.87 (0.73 - 1.05) 0.94 (0.78 - 1.12) 0.97 (0.80 - 1.16)
Annual household Income < $20K 1.53 (1.28 - 1.83) 1.44 (1.21 - 1.72) 1.30 (1.08 - 1.55)
Body mass index, per 5 kg/m2 0.94 (0.88 - 1.01) 0.89 (0.83 - 0.96) 0.91 (0.85 - 0.97)
Hypertension * 1.20 (1.00 - 1.44) 1.21 (1.01 - 1.45)
Myocardial infarction * 1.35 (1.14 - 1.60) 1.31 (1.11 - 1.55)
Stroke * 1.45 (1.20 - 1.74) 1.35 (1.12 - 1.63)
Diabetes Mellitus * 1.59 (1.37 - 1.86) 1.56 (1.33 - 1.81)
Aspirin * 0.89 (0.76 - 1.05) 0.89 (0.76 - 1.04)
Beta blocker * 1.18 (1.02 - 1.37) 1.17 (1.01 - 1.36)
Thienopyridine * 1.36 (1.13 - 1.64) 1.36 (1.13 - 1.64)
Ace-inhibitor / angiotensin receptor blocker * 1.05 (0.90 - 1.22) 1.06 (0.91 - 1.23)
Statin * 0.73 (0.63 - 0.85) 0.75 (0.64 - 0.87)
Alcohol use
None
Light to moderate
High
* *
1 (ref)
0.92 (0.78 - 1.09)
0.69 (0.43 - 1.10)
Current Smoking * * 2.07 (1.72 - 2.49)
Physical activity
None
1 -3 times per week
≥ 4 times per week
* *
1 (ref)
0.68 (0.57 - 0.81)
0.67 (0.56 - 0.81)
Morisky scale for medication adherence
0
1
2
3 or 4
* *
1 (ref)
1.15 (0.98 - 1.36)
1.24 (0.91 - 1.69)
0.80 (0.51 - 1.25)
